ARCHIVES

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

This article is from The Cancer Letter archive.

Vol. 33 No. 02 | January 19, 2007

Download PDF Visit The Full Archive

Related Articles

Prominent Duke Scientist Claimed Prizes He Didn’t Win, Including Rhodes Scholarship

July 16, 2010

NCAB ‘Incredulous’ Over Proposed Ethics Rules, Bard Members Threaten Resignation In Letter

October 4, 1991

Five Contracts Funded Under Unconventional Innovations Program

October 22, 1999

Fibrolast Interferon Contract Signed

May 2, 1980

Rituxan Approved as Maintenance For Advanced Follicular Lymphoma

February 25, 2011

Four New CCOPs Awarded To Fill Geographical Gaps – Mississippi, Ft. Worth, Fresno, Vermont

September 16, 1983